halofuginone

Also Known As:

(+)-halofuginone; (+- )- trans- 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidyl)- acetonyl)- 4(3H)- quinazolinone; (+- )- trans- 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidyl)- acetonyl)- 4(3H)- quinazolinone monohydrobromide; (-)-halofuginone; (-)-halofuginone hydrobromide; 4(3H)-quinazolinone, 7- bromo- 6- chloro- 3- (3- ((2R,3S)- 3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- , hydrochloride (1:1), rel-; 4(3H)-quinazolinone, 7- bromo- 6- chloro- 3- (3- ((2S,3R)- 3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- , hydrobromide (1:1); 4(3H)-quinazolinone, 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- , hydrobromide, trans-(+-)-; 4(3H)-quinazolinone, 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- , trans-, mono(2-hydroxypropanoate)(salt); 6-chloro-7-bromo-(+)-febrifugine; 6-chloro-7-bromofebrifugine; 7- bromo- 6- chloro- 3,3- (3- hydroxy- 2- piperidyl)acetonyl- 4(3H)- quinazolinone- hydrolactate; 7- bromo- 6- chloro- 3- (3- ((2R,3S)- 3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- 4(3H)- quinazolinone; 7- bromo- 6- chloro- 3- (3- ((2S,3R)- 3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- 4(3H)- quinazolinone; 7- bromo- 6- chloro- 3- (3- ((2S,3R)- 3- hydroxy- 2- piperidyl)- 2- oxo- propyl)quinazolin- 4- one hydrobromide; 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidinyl)- 2- oxopropyl)- 4(3H)- quinazolinone; 7-bromo-6-chlorofebrifugine; Cebegine; Halagon; Halocur; RU 19110; RU-19110; RU19110; Stenorol; chloro-bromofebrifugine; chlorobromofebrifugine; halofuginon; halofuginone HBr; halofuginone HCl; halofuginone hydrobromide; halofuginone hydrobromide, (-)-; halofuginone hydrochloride; halofuginone lactate; halofuginone monohydrobromide; halofuginone monohydrochloride; halofuginone, (+)-; halofuginone, (-)-; halofunginone; trans- 7- bromo- 6- chloro- 3- (3- (3- hydroxy- 2- piperidyl)- acetonyl)- 4(3H)- quinazolinone

Pharmalogical Action Categories:

D000970 - Antineoplastic Agents
D003049 - Coccidiostats
D011500 - Protein Synthesis Inhibitors
D020533 - Angiogenesis Inhibitors

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - halofuginone: 274
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 423
      - Quinazolinones: 128
        halofuginone: 274

Kathy C Flanders Selected Research

Kathy C Flanders Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure